Emodin has been proven to have weight-reducing and lipid-lowering effects. In order to make emodin play a better anti-obesity role, we designed and developed an emodin loaded dissolving microneedle patch, in which emodin existed in the form of emodin-polyvinylpyrrolidone co-precipitate (Emodin-PVP). Meanwhile, polydopamine (PDA) was added to the microneedle patch (PDA-Emodin-PVP-MN) for photothermal-enhanced chemotherapy of obesity. The drug loading of PDA-Emodin-PVP-MN was 0.37 ± 0.025 mg per patch, and the cumulative release of the microneedle patch was up to 96.25% under NIR irradiation (808 nm, 0.6 W/cm 2 ). The microneedle patch with NIR radiation significantly reduced body weight, waist circumference, lipid-body ratio and serum free fatty acids of the obese model rats, and the volume of adipocytes of fat droplets was significantly reduced after the treatment with microneedle patch under NIR radiation. No obvious toxicity was observed in hemolytic test and microscopic histopathological analysis . The mechanism of action of the weight-reducing might be ascribed to the expression level of hormone-sensitive lipase (HSL) and lipoprotein lipase (LPL) involved in fat metabolism.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: